Irbesartan-loaded cRGD-modified PLGA nanoparticles attenuate intervertebral disc degeneration through an FGFR1-related mechanism
Authors: Yu, Xiao-Jun; Wang, Ying-Guang; Wang, Shan-Xi; Li, Ling-Jiang; Lin, Kai-Yuan; Wang, Ren-Ji; Luo, Rong-Jin; Guan, Jian-Bin; Wang, Si-Bo; Yan, Liang
Source journal: Biomarker research (2026-11-18)
DOI: 10.1186/s40364-026-01041-8
Abstract
BACKGROUND: Intervertebral disc degeneration (IDD) lacks effective disease-modifying therapy. This study evaluated the protective effects of irbesartan (Ir), explored fibroblast growth factor receptor 1 (FGFR1) as a candidate molecular mediator, and assessed whether cRGD modification could enhance nanoparticle uptake and local treatment effects. METHODS: Rat IDD models and IL-1beta-induced degenerative nucleus pulposus cells were used to assess free Ir and Ir-loaded cRGD-modified PLGA nanoparticles (cRGD-NPs@Ir). Bioinformatics screening, cellular thermal shift assay (CETSA), and molecular docking were used to nominate FGFR1 as a candidate Ir-associated protein, and FGFR1 knockdown was used to test whether FGFR1 status modified the treatment response. Imaging, histology, immunohistochemistry, Western blotting, RT-qPCR, nanoparticle characterization, Coumarin-6 uptake assays, and tandem LC3 reporter analysis were used to evaluate treatment-associated changes. RESULTS: Ir attenuated structural and molecular features of IDD, reduced MAPK/NF-kappaB signaling, altered autophagy-associated markers, and preserved extracellular matrix homeostasis. FGFR1 expression was lower in degenerative disc tissue, and FGFR1 knockdown attenuated several protective changes associated with Ir or cRGD-NPs@Ir. cRGD-NPs@Ir produced greater carrier-associated Coumarin-6 uptake than NPs@Ir and larger treatment-associated changes than free Ir for several directly compared endpoints. These findings support an FGFR1-related component of the response but do not establish direct Ir-FGFR1 binding, receptor-specific cRGD targeting, or exclusive FGFR1 dependence. CONCLUSIONS: FGFR1 may contribute as a candidate molecular mediator to Ir-associated changes in autophagy and inflammatory signaling in IDD. cRGD-NPs@Ir provides an uptake-enhancing local nanodelivery strategy, although receptor specificity and direct Ir-FGFR1 binding require further validation.
Related topics
Related open access articles
- Development and Validation Molecular Docking Analysis of Human serum albumin (HSA)
- Facing COVID-19 via anti-inflammatory mechanism of action: Molecular docking and Pharmacokinetic studies of six anti-inflammatory compounds derived from Passiflora edulis
- Computational analysis by molecular docking of thirty alkaloid compounds from medicinal plants as potent inhibitors of SARS-CoV-2 main protease
- Curcumin and pipernonaline to curb diabetes the natural way: A molecular modeling, docking and dynamics simulation study
- DENSITY FUNCTIONAL THEORY ANALYSIS AND MOLECULAR DOCKING EVALUATION OF 8-CHLOROQUINOLINE 2-CARBALDEHYDE
- Thermochemical, DFT, Molecular Docking and Pharmacokinetic Studies of Methyl β-D-galactopyranoside Esters
Abstract and bibliographic data from PubMed (U.S. National Library of Medicine). Copyright of the abstract belongs to the original publisher or authors.